Insights & Analysis
Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.
More articles — Page 15
Page 15 of 112 · 1007 articles
Auto-Refill Programs and PBM Audit Exposure
Auto-refill and refill-reminder programs create their own PBM audit findings: unrequested fills, missing consent records, and stoc…
Missouri MMAC Medicaid Audits and Provider Defense
MMAC reviews MO HealthNet provider billing, can extrapolate an overpayment from a sample, and gives a provider 30 days to appeal t…
DEA Form 82 Notice of Inspection: What You Are Signing
DEA Form 82 asks a pharmacist to sign away the right to a warrant. What the consent line waives, and when the warrant alternative…
Chain Pharmacy Quotas and DEA Corresponding Responsibility Liability
DOJ settlements with CVS and Walmart in 2026 tie corporate performance metrics and pharmacist staffing to DEA corresponding respon…
California Sterile Compounding License and Board Inspection Issues
California requires a separate sterile compounding license, a pre-renewal inspection, and new rules for nonresident pharmacies shi…
Buying a Compounding Pharmacy: FDA and Board Due Diligence
A buyer's pre-closing checklist: FDA 483s, warning letters, EIRs, board inspection records, sterility failure history, and license…
Who Can Bill RPM in a Nursing Facility: Physicians, Facilities and Vendors
A nursing facility's Part A consolidated billing rule can require the facility, not the ordering physician or its RPM vendor, to b…
UPIC Audits of Wound Care in Nursing Facilities
A $45M DOJ settlement with a bedside wound care provider shows how UPIC audits reach nursing facility records, not just the billin…
RPM Vendor Arrangements With Nursing Homes and the Anti-Kickback Statute
Free devices, per-resident fees, and revenue shares RPM vendors offer nursing homes can be Anti-Kickback Statute remuneration with…